David Hellerstein, MD

Validation of Goal Attainment Scaling for Depression: Initial Findings From an Open-label Study in Patients Switching to Vortioxetine

Goal attainment scaling (GAS) for evaluating individualized patient treatment goals and progress was adapted for MDD (GAS-D) in an open-label study in patients switching to vortioxetine (...

Maggie McCue , MS, RD;

Lambros Chrones , MD;

Anna Eramo , MD;

Mark Opler , PhD, MPH;

Andrea Norcini Pala , PhD;

Sagar Parikh , MD;

David Hellerstein , MD;

03/01/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

David Hellerstein, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products